{"id":146306,"date":"2021-10-08T20:04:00","date_gmt":"2021-10-08T20:04:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2927501"},"modified":"2021-10-08T20:04:00","modified_gmt":"2021-10-08T20:04:00","slug":"covid-19-diagnostics-market-size-2021-26-industry-overview-trends-share-growth-opportunity-and-forecast","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/10\/08\/covid-19-diagnostics-market-size-2021-26-industry-overview-trends-share-growth-opportunity-and-forecast\/","title":{"rendered":"Covid-19 Diagnostics Market Size 2021-26: Industry Overview, Trends, Share, Growth, Opportunity and Forecast"},"content":{"rendered":"

According to the latest report by IMARC Group, titled “<\/strong>Covid-19 Diagnostics Market Share<\/strong><\/a>:<\/strong> Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”<\/strong> The global COVID-19 diagnostics market is expected to continue its strong growth during the next five years.<\/p>\n

COVID-19 is a highly infectious disease generated by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat, body aches, etc. The infection is diagnosed through several clinical tests, such as reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing, etc. These tests use kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP), human saliva, nasal swabs, or blood. They are adopted by hospitals, laboratories, clinics, research institutes, and diagnostic centers.<\/p>\n

As the novel coronavirus (COVID-19)<\/strong> crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.<\/p>\n

Global Covid-19 Diagnostics Market<\/strong> Trends:<\/strong><\/p>\n

The sudden outbreak of coronavirus disease and a significant increase in the number of COVID-19 infected patients are primarily driving the global market for COVID-19 diagnostics. The escalating number of daily cases has resulted in the extensive adoption of diagnostic tests for rapid and comprehensive testing to facilitate early treatment for the patients. Additionally, the introduction of novel antibody and serology test kits for home-testing that consume less time and can be integrated with software-based programs for accurate results is further augmenting the product demand. Numerous other factors, including the launch of favorable government policies to contain the spread of COVID-19 infection and ongoing improvements in the healthcare infrastructures, are anticipated to drive the market growth in the coming years.<\/p>\n

Request Free Sample Report: <\/strong>https:\/\/www.imarcgroup.com\/covid-19-diagnostics-market\/requestsample<\/strong><\/a><\/p>\n

Global <\/strong>Covid-19 Diagnostics Market<\/strong> 2<\/strong>021-2026 Analysis and Segmentation: <\/strong><\/p>\n

Competitive Landscape:<\/strong><\/p>\n

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.<\/p>\n

Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.<\/p>\n

The report has segmented the market on the basis on region, product type, sample type, test type, mode and end use.<\/p>\n

Breakup by Product Type:<\/strong><\/p>\n